These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 12605593

  • 1. Sodium/lithium countertransport and intracellular calcium concentration in patients with essential hypertension and coronary heart disease.
    Gruska S, Jendral I, Rettig R, Kraatz G.
    Clin Sci (Lond); 2003 Mar; 104(3):323-7. PubMed ID: 12605593
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
    Vaccaro O, Cuomo V, Trevisan M, Cirillo M, Panarelli W, Laurenzi M, Mancini M, Riccardi G, Gubbio Study Research Group.
    Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
    Kosmidou MS, Hatzitolios AI, Adamidou A, Giannopoulos S, Raikos N, Parharidis G, Milionis HJ.
    Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
    [Abstract] [Full Text] [Related]

  • 8. [Red-cell sodium-lithium countertransport in patients with IgA nephrology and renal hypertension].
    Chen YD, Zheng FL, Wen LR.
    Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):214-7, 254. PubMed ID: 7922761
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Copper modifies the activity of sodium-transporting systems in erythrocyte membrane in patients with essential hypertension.
    Kedzierska K, Bober J, Ciechanowski K, Gołembiewska E, Kwiatkowska E, Noceń I, Dołegowska B, Dutkiewicz G, Chlubek D.
    Biol Trace Elem Res; 2005 Oct; 107(1):21-32. PubMed ID: 16170219
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Red blood cell sodium-lithium countertransport in patients with essential and renal hypertension.
    Petrov VV, Arabidze CG, Levitsky DO, Eliseev AO, Lijnen PJ.
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):153-7. PubMed ID: 8007744
    [Abstract] [Full Text] [Related]

  • 13. Sodium-lithium countertransport activity in healthy, dyslipidemic, and hypertensive individuals.
    Savopoulos CG, Hatzitolios AI, Katsiki NA, Baltatzi M, Kosmidou M, Raikos N, Mikhailidis DP, Ziakas AG, Kaiafa G, Tsesmeli N.
    Angiology; 1994 Mar; 59(6):727-35. PubMed ID: 18840623
    [Abstract] [Full Text] [Related]

  • 14. [Changes of the new gaseous transmitter H2S in patients with coronary heart disease].
    Jiang HL, Wu HC, Li ZL, Geng B, Tang CS.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):951-4. PubMed ID: 16109547
    [Abstract] [Full Text] [Related]

  • 15. A biometrical study of the relationship between sodium-lithium countertransport and triglycerides.
    Stengård JH, Zerba KE, Turner ST, Sing CF.
    Ann Hum Genet; 1997 Mar; 61(Pt 2):121-36. PubMed ID: 9177119
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Intracellular calcium and sodium-lithium countertransport in type 2 diabetic patients with and without albuminuria.
    Völzke H, Gruska S, Vogelgesang D, Kerner W, Kraatz G, Rettig R.
    Endocr J; 2006 Dec; 53(6):773-81. PubMed ID: 16983181
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.